A detailed history of Exchange Traded Concepts, LLC transactions in Agenus Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 475,130 shares of AGEN stock, worth $7.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
475,130
Previous 107,019 343.97%
Holding current value
$7.93 Million
Previous $88,000 212.5%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$0.53 - $0.93 $195,098 - $342,343
368,111 Added 343.97%
475,130 $275,000
Q4 2023

Jan 05, 2024

BUY
$0.63 - $1.14 $17,096 - $30,936
27,137 Added 33.97%
107,019 $88,000
Q3 2023

Oct 18, 2023

BUY
$1.12 - $1.88 $8,243 - $13,836
7,360 Added 10.15%
79,882 $90,000
Q2 2023

Jul 20, 2023

BUY
$1.31 - $2.04 $95,003 - $147,944
72,522 New
72,522 $116,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.